UK scientists slow Huntington's disease for first time
PositiveWorld Affairs

UK scientists have made a significant breakthrough in the fight against Huntington's disease, announcing that their new gene therapy, AMT-130, has successfully slowed the progression of the disease in early-stage trials. Conducted at University College London, the therapy demonstrated that some patients experienced a 75% slower decline over three years. This advancement is crucial as it offers hope for better management of a condition that has long been considered challenging to treat.
— Curated by the World Pulse Now AI Editorial System